Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Unknown 4 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Motor Activity 2 Neuralgia 1 Neoplasms 1 Lung Neoplasms 1 Breast Neoplasms 1

Interventions

Paclitaxel 62 Letrozole 56 Fulvestrant 54 Trastuzumab 50 palbociclib 42 pembrolizumab 38 Cyclophosphamide 37 Carboplatin 37 Anastrozole 37 pertuzumab 35 exemestane 25 abemaciclib 24 Tamoxifen 24 Capecitabine 24 ribociclib 22 Radiotherapy 21 Docetaxel 21 olaparib 20 Doxorubicin 20 Magnetic Resonance Spectroscopy 19 trastuzumab deruxtecan 17 Surveys and Questionnaires 17 Epirubicin 17 durvalumab 16 Specimen Handling 14 Exercise 14 130-nm albumin-bound paclitaxel 14 Taxes 13 Alpelisib 13 Gonadotropin-Releasing Hormone 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Breast Neoplasms × Exercise Therapy × Clear all

NCT06754293 2024-12-31

RE-MS

Fudan University

Phase NA Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡